Advocacy intelligence hub — real-time data for patient organizations
JCR Pharmaceuticals Co., Ltd. — PHASE1, PHASE2
West China Hospital — PHASE1
Denali Therapeutics Inc. — PHASE1, PHASE2
JCR Pharmaceuticals Co., Ltd. — PHASE1, PHASE2
University of Manchester — PHASE1, PHASE2
Masonic Cancer Center, University of Minnesota
University of California, San Francisco — PHASE1
University of Manchester — PHASE1, PHASE2
REGENXBIO Inc. — PHASE2, PHASE3
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Paul Orchard, MD, MD
University of Minnesota Medical Center
📍 MINNEAPOLIS, MN
Tippi C MacKenzie, MD
University of California, San Francisco
📍 San Francisco, California
Patricia I Dickson, MD
Los Angeles Biomedical Institute at Harbor-UCLA
Paul Orchard, M.D., MD
Masonic Cancer Center, University of Minnesota
📍 MINNEAPOLIS, MN
Lynda E Polgreen, MD, MS, MD
Los Angeles BioMedical Research Center at Harbor-UCLA
📍 ORANGE, CA
Robert Wynn
MFT